NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/26/2025
Back to search
Official data from USPTO
LAUNCH THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
LAUNCH THERAPEUTICS
ST13
US500000097532949Class
35, 42
Filing
97532949
Registration
7922243
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
08/26/2025
Classification
Registered
Trademark type
Word
Nice classes
35, 42
Filing date
08/03/2022
Registration date
08/26/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/26/2025
Last transaction
08/26/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/31/2022
First use in commerce
08/31/2022
Drawing code
4
Owner type
03
Owner location
Boston, MA, US
Examiner
FLORES, SHAKEYLA NO MIDDLE NAME
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
L. T. (pessoa física)
Representatives
Heather A. Dunn, Esq. DLA PIPER LLP (US)
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business advisory services for the pharmaceutical and biotechnology industry; business consulting and management in the field of clinical trials
Class 42
Medical and scientific researchconducting clinical trials for others
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/26/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/06/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/06/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/06/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/27/2024
EX1G
SOU EXTENSION 1 GRANTED
02/26/2024
EXT1
SOU EXTENSION 1 FILED
02/26/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/26/2024
IUAF
USE AMENDMENT FILED
02/23/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/23/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/01/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/01/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/01/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/01/2023
DOCK
ASSIGNED TO EXAMINER
05/20/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/09/2022
NWAP
NEW APPLICATION ENTERED
08/06/2022
Continuous trademark protection
Get notified about every new filing that threatens LAUNCH THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.